Enhanced mRNA expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in breast carcinomas is correlated with adverse prognosis
2002 · The Journal of Pathology · 90 citations
https://doi.org/10.1002/path.1129
L
Lydia Nakopoulou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
2.9K
Citations
30
h-index
65
i10-index
Lydia Nakopoulou is an academic researcher from Glenmark Pharmaceuticals (India). The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Protease and Inhibitor Mechanisms & Peptidase Inhibition and Analysis. The author has an h-index of 30, co-authored 80 publications.
Papers by this author
worksExpression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
2008 · Breast Cancer Research · 88 citations
https://doi.org/10.1186/bcr2103
Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome
2006 · Modern Pathology · 70 citations
https://doi.org/10.1038/modpathol.3800562
DNA Topoisomerase II-Alpha Immunoreactivity as a Marker of Tumor Aggressiveness in Invasive Breast Cancer
2000 · Pathobiology · 70 citations
https://doi.org/10.1159/000055914
The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma
2006 · Gynecologic Oncology · 66 citations
https://doi.org/10.1016/j.ygyno.2006.09.031
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome
2006 · Breast Cancer Research · 50 citations
https://doi.org/10.1186/bcr1607
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat